Wolverine Trading
RNVA

Wolverine Trading’s Rennova Health, Inc. RNVA Stock Holding History

Wolverine Trading’s Portfolio RNVA Stock Details RNVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-25
Closed -$1K – 5495
2016
Q4 		$1K Buy
25
+1
+4% +$57 ﹤0.01% 4355
2016
Q3 		$2K Buy
+24
New +$3.15K ﹤0.01% 4553

Other funds holding RNVA

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Wolverine Trading's RNVA Position: Q1 2017 in Review

Wolverine Trading sold out of Rennova Health, Inc. (RNVA) in Q1 2017, closing a stake of 25 shares — an estimated $1K sold.

Wolverine Trading first reported a position in RNVA in Q3 2016 and held it in 2 quarters. The position peaked at $2K in Q3 2016. 9 funds tracked by Wall St. Rank hold RNVA as of Q1 2017.

  • Wolverine Trading reported no remaining Rennova Health, Inc. position as of Q1 2017 after selling out during the quarter.
  • Wolverine Trading sold 25 Rennova Health, Inc. shares in Q1 2017, an estimated $1K.
  • Wolverine Trading first reported a position in Rennova Health, Inc. in Q3 2016 and held it in 2 quarters.
  • Wolverine Trading's Rennova Health, Inc. position peaked at $2K in Q3 2016.
  • 9 funds tracked by Wall St. Rank held Rennova Health, Inc. as of Q1 2017.

Based on Wolverine Trading's 13F filing for Q1 2017, filed 15 May 2017.